Peter Fischer

4.6k total citations · 2 hit papers
92 papers, 3.3k citations indexed

About

Peter Fischer is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Psychiatry and Mental health. According to data from OpenAlex, Peter Fischer has authored 92 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 13 papers in Radiology, Nuclear Medicine and Imaging and 12 papers in Psychiatry and Mental health. Recurrent topics in Peter Fischer's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Schizophrenia research and treatment (8 papers) and Biomedical Research and Pathophysiology (6 papers). Peter Fischer is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Schizophrenia research and treatment (8 papers) and Biomedical Research and Pathophysiology (6 papers). Peter Fischer collaborates with scholars based in Germany, Austria and United States. Peter Fischer's co-authors include Andreas Weidemann, Konrad Beyreuther, Colin L. Masters, Gerhard König, Dirk Bunke, J. Michael Salbaum, Donald L. Price, Sangram S. Sisodia, David R. Archer and Lee J. Martin and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Peter Fischer

87 papers receiving 3.2k citations

Hit Papers

Identification, biogenesis, and localization of precursor... 1989 2026 2001 2013 1989 1990 250 500 750 1000

Peers

Peter Fischer
Barbara A. Cottrell United States
Martin Paul Germany
Michael R. D’Andrea United States
Frauke Neff Germany
Paul Honegger Switzerland
Min Zhu China
Barbara A. Cottrell United States
Peter Fischer
Citations per year, relative to Peter Fischer Peter Fischer (= 1×) peers Barbara A. Cottrell

Countries citing papers authored by Peter Fischer

Since Specialization
Citations

This map shows the geographic impact of Peter Fischer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Fischer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Fischer more than expected).

Fields of papers citing papers by Peter Fischer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Fischer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Fischer. The network helps show where Peter Fischer may publish in the future.

Co-authorship network of co-authors of Peter Fischer

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Fischer. A scholar is included among the top collaborators of Peter Fischer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Fischer. Peter Fischer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
König, Theresa, Raphael Wurm, Christoph Hotzy, et al.. (2022). C9orf72 repeat length might influence clinical sub-phenotypes in dementia patients. Neurobiology of Disease. 175. 105927–105927. 6 indexed citations
2.
Has, Cristina, May El Hachem, Hana Bučková, et al.. (2021). Practical management of epidermolysis bullosa: consensus clinical position statement from the European Reference Network for Rare Skin Diseases. Journal of the European Academy of Dermatology and Venereology. 35(12). 2349–2360. 16 indexed citations
3.
Fischer, Peter, Rosemarie Pöthig, & Markus Venohr. (2017). The degree of phosphorus saturation of agricultural soils in Germany: Current and future risk of diffuse P loss and implications for soil P management in Europe. The Science of The Total Environment. 599-600. 1130–1139. 67 indexed citations
4.
Rainer, Michael, et al.. (2011). [Memory clinics in Austria - characteristics and patterns of practice].. PubMed. 25(1). 9–15. 2 indexed citations
5.
Fischer, Peter, Susanne Jungwirth, Silvia Weissgram, et al.. (2007). Cumulative Exposure to General Anesthesias and Cognitive Dysfunction at Age 75 in the Vienna Transdanube Aging “VITA” Study. Journal of Neuropsychiatry. 19(1). 21–26. 12 indexed citations
7.
Fischer, Peter, et al.. (2002). Pathophysiologische Korrelate deliranter Syndrome. Journal für Kardiologie (Krause & Pachernegg GmbH). 3(3). 32–40. 4 indexed citations
8.
Fischer, Peter, J. Tauscher, B. Küfferle, & Siegfried Kasper. (1998). Weak antidepressant response after buspirone augmentation of serotonin reuptake inhibitors in refractory severe depression. International Clinical Psychopharmacology. 13(2). 83–86. 11 indexed citations
9.
Wrasidlo, Wolf, et al.. (1998). Monoclonal Antibody 138H11 against Gamma-Glutamyltransferase Provides a Possible Tool for Targeting Calicheamicin θ to Renal Cell Carcinomas. Advances in experimental medicine and biology. 451. 431–436. 3 indexed citations
10.
Kaufmann, O., Manfred Dietel, Jürgen E. Scherberich, Gerhard Gaedicke, & Peter Fischer. (1997). Immunohistochemical differentiation of metastases of renal carcinomas versus other carcinomas with anti‐γGT monoclonal antibody 138H11. Histopathology. 31(1). 31–37. 7 indexed citations
11.
Yang, Yi‐Yuan, et al.. (1997). IgG rheumatoid factors isolated by the surface-displaying phage library technique. Immunogenetics. 45(5). 301–310. 8 indexed citations
12.
Meyer‐Franke, Anke, Michael B. Tropak, John Roder, et al.. (1995). Functional topography of myelin‐associated glycoprotein. II. Mapping of domains on molecular fragments. Journal of Neuroscience Research. 41(3). 311–323. 12 indexed citations
13.
Fischer, Peter, et al.. (1992). Immunoscintigraphic localization of renal tumours in an extracorporeal perfusion model with a monoclonal antibody against γ-glutamyltransferase. Cancer Immunology Immunotherapy. 35(4). 283–288. 7 indexed citations
14.
Fischer, Peter, W Danielczyk, K. A. Jellinger, et al.. (1991). Clinico pathological classification of dementia. Der Nervenarzt. 62(7). 408–414. 1 indexed citations
15.
Bush, Ashley I., Ralph N. Martins, B. Rumble, et al.. (1990). The amyloid precursor protein of Alzheimer's disease is released by human platelets.. Journal of Biological Chemistry. 265(26). 15977–15983. 270 indexed citations
16.
Fischer, Peter, Jürgen E. Scherberich, & W. Schoeppe. (1990). Comparative biochemical and immunological studies on gamma-glutamyltransferases from human kidney and renal cell carcinoma applying monoclonal antibodies. Clinica Chimica Acta. 191(3). 185–200. 19 indexed citations
17.
Gatterer, Gerald, Peter Fischer, M Simányi, & W Danielczyk. (1989). The A-K-T ("Alters-Konzentrations-Test") a new psychometric test for geriatric patients.. PubMed. 4(3). 273–6. 14 indexed citations
19.
Fischer, Peter, et al.. (1954). Métabolisme De La Cystéamine Et De La Cystamine Chez Le Lapin Et Le Chien. Archives Internationales de Physiologie. 62(1). 76–100. 10 indexed citations
20.
Cauwenberge, H. Van, et al.. (1953). Action de la mercaptoéthylamine sur la teneur en acide ascorbique des glandes surrénales du Rat. Archives Internationales de Physiologie. 61(1). 124–127. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026